Metraipolis › archive › dc_41442a4e97da

Tegoprazan dual and quadruple therapy for Helicobacter pylori eradication: a prospective, randomized controlled trial in Beijing, China — Europe PMC PMID:40873796

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40873796
DOI: 10.3389/fmed.2025.1629567
License (as archived): solo-consultazione
Archived: 2026-11-10T17:28:58.374Z
SHA-256 of the archived text: 26862fbfc5ec21f0d8ceabebf6449133371042d42f4ec50406755648ed7bfd6e
Stable URL of this page: https://metraipolis.com/documento/dc_41442a4e97da

How to cite

Tegoprazan dual and quadruple therapy for Helicobacter pylori eradication: a prospective, randomized controlled trial in Beijing, China — Europe PMC PMID:40873796 — Europe PMC (en), https://europepmc.org/article/MED/40873796 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_41442a4e97da (Metraipolis archive dc_41442a4e97da, sha256 26862fbfc5ec21f0d8ceabebf6449133371042d42f4ec50406755648ed7bfd6e)

BibTeX

@misc{dc41442a4e97da,
  title = {Tegoprazan dual and quadruple therapy for Helicobacter pylori eradication: a prospective, randomized controlled trial in Beijing, China — Europe PMC PMID:40873796},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40873796},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_41442a4e97da; sha256 26862fbfc5ec21f0d8ceabebf6449133371042d42f4ec50406755648ed7bfd6e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40873796. Agents can read the archived copy with the MCP tool read_document.